Presentation is loading. Please wait.

Presentation is loading. Please wait.

Log faecal calprotectin concentration (mg/l) in the different diagnostic groups. Log faecal calprotectin concentration (mg/l) in the different diagnostic.

Published byLucas Möller Modified over 5 years ago

Similar presentations

Presentation on theme: "Log faecal calprotectin concentration (mg/l) in the different diagnostic groups. Log faecal calprotectin concentration (mg/l) in the different diagnostic."— Presentation transcript:

1 Log faecal calprotectin concentration (mg/l) in the different diagnostic groups.
Log faecal calprotectin concentration (mg/l) in the different diagnostic groups. Median values with 95% (+) and 5% (–) confidence intervals are shown. All three diagnostic groups differed significantly from controls (normal/irritable bowel syndrome, p=0.01; adenomatous polyps, p=0.0003; cancer p<0.0001). J Tibble et al. Gut 2001;49: Copyright © BMJ Publishing Group Ltd & British Society of Gastroenterology. All rights reserved.

Download ppt "Log faecal calprotectin concentration (mg/l) in the different diagnostic groups. Log faecal calprotectin concentration (mg/l) in the different diagnostic."

Similar presentations

distinguishing IBD versus D-IBS.

distinguishing IBD versus D-IBS.
Oligonucleotide sequences of polymerase chain reaction (PCR) primers and competitive templates. Oligonucleotide sequences of polymerase chain reaction.

Oligonucleotide sequences of polymerase chain reaction (PCR) primers and competitive templates. Oligonucleotide sequences of polymerase chain reaction.
Tracings of concurrent oesophageal manometry, pH, and impedance.

Tracings of concurrent oesophageal manometry, pH, and impedance.
Whiskers boxplot (5th–95th centile) representing the C-reactive protein concentration (mg/L) in samples with an infliximab (IFX) trough concentration above.

Whiskers boxplot (5th–95th centile) representing the C-reactive protein concentration (mg/L) in samples with an infliximab (IFX) trough concentration above.
Comparison of DNA rates between standard lists and BCSP lists across UK. BCSP, Bowel Cancer Screening Programme; DNA, did not attend; NHS, National Health.

Comparison of DNA rates between standard lists and BCSP lists across UK. BCSP, Bowel Cancer Screening Programme; DNA, did not attend; NHS, National Health.
Chart 3: Working example of oxygen section for hospital prescription charts (two panels are required on the prescription chart because oxygen may change.

Chart 3: Working example of oxygen section for hospital prescription charts (two panels are required on the prescription chart because oxygen may change.
Sedentary time was higher in non-alcoholic fatty liver disease (NAFLD) than healthy controls with fewer sedentary to active transitions (data reported.

Sedentary time was higher in non-alcoholic fatty liver disease (NAFLD) than healthy controls with fewer sedentary to active transitions (data reported.
A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.

A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.
Scores of 64 irritable bowel syndrome (IBS) patients (top figure).

Scores of 64 irritable bowel syndrome (IBS) patients (top figure).
Audit data for new outpatient attendances in August 2014 following GP referral at Taunton and Somerset NHS Foundation Trust (TST) and Yeovil District NHS.

Audit data for new outpatient attendances in August 2014 following GP referral at Taunton and Somerset NHS Foundation Trust (TST) and Yeovil District NHS.
Individual patients’ FCP (μg/g) values (n=119).

Individual patients’ FCP (μg/g) values (n=119).
Masashi Maeda et al. Heart Asia 2013;5:7-14

Masashi Maeda et al. Heart Asia 2013;5:7-14
Preprocedure patient ranking of aspects of their care important for obtaining satisfaction with their colonoscopy experience (1=high, 15=low for importance)

Preprocedure patient ranking of aspects of their care important for obtaining satisfaction with their colonoscopy experience (1=high, 15=low for importance)
Modelled changes in gastrointestinal endoscopy activity 2013/2014 to 2019/2020.43 2WW, 2-week wait; BCSP, Bowel Cancer Screening Programme; FIT, faecal.

Modelled changes in gastrointestinal endoscopy activity 2013/2014 to 2019/ WW, 2-week wait; BCSP, Bowel Cancer Screening Programme; FIT, faecal.
Integration of prognostic screening tool and development of supportive care intervention using rapid-cycle ‘Plan-Do-Study-Act’ (PDSA) methodology. Integration.

Integration of prognostic screening tool and development of supportive care intervention using rapid-cycle ‘Plan-Do-Study-Act’ (PDSA) methodology. Integration.
Distinguishing organic disease versus D-IBS.

Distinguishing organic disease versus D-IBS.
Respondent suggestions as to how best to protocol case selection for the inflammatory bowel disease (IBD) multidisciplinary team (MDT)—application of an.

Respondent suggestions as to how best to protocol case selection for the inflammatory bowel disease (IBD) multidisciplinary team (MDT)—application of an.
Eligibility criteria for inclusion as an expert Delphi panellist

Eligibility criteria for inclusion as an expert Delphi panellist
Comparison of the delay from referral to endoscopy for subjects with confirmed iron deficiency anaemia, before and after introduction of the Poole iron.

Comparison of the delay from referral to endoscopy for subjects with confirmed iron deficiency anaemia, before and after introduction of the Poole iron.
ROC plots of the association of this score, the Rockall Score and the Blatchford Score with RET (a), death (b), and the combined Blatchford outcome (c)

ROC plots of the association of this score, the Rockall Score and the Blatchford Score with RET (a), death (b), and the combined Blatchford outcome (c)

Similar presentations

Ads by Google